{
    "clinical_study": {
        "@rank": "28308", 
        "arm_group": [
            {
                "arm_group_label": "Zinc  level (micro gram per deciliter)", 
                "description": "In all cases"
            }, 
            {
                "arm_group_label": "Selenium level (micro gram per deciliter)", 
                "description": "In all cases"
            }, 
            {
                "arm_group_label": "Zinc level in male (micro gram per deciliter)"
            }, 
            {
                "arm_group_label": "Selenium level in male (micro gram per deciliter)"
            }, 
            {
                "arm_group_label": "Zinc level in Female (micro gram per decilitre)"
            }, 
            {
                "arm_group_label": "Selenium level in Female (micro gram per decilitre)"
            }
        ], 
        "biospec_descr": {
            "textblock": "Serum were analysis for zinc and selenium"
        }, 
        "biospec_retention": "None Retained", 
        "brief_summary": {
            "textblock": "This study was carried out with the purpose of evaluating zinc and selenium levels in serum\n      of epileptic patients  and compare with normal individuals."
        }, 
        "brief_title": "Study on Serum Zinc and Selenium Levels in Epileptic Patients", 
        "completion_date": {
            "#text": "May 2012", 
            "@type": "Actual"
        }, 
        "condition": "Generalized Epileptic", 
        "condition_browse": {
            "mesh_term": "Epilepsy"
        }, 
        "detailed_description": {
            "textblock": "Forty patients aged 18 to 50 years visiting Vali-Asr hospital in Arak, I.R. Iran, who were\n      diagnosed with generalized form of epilepsy by a neurologist for the first time were\n      recruited as cases. The control group (n=40) was selected from healthy individuals, in whom\n      no disease was diagnosed until this study, and were matched to the case group by age, sex,\n      and economical status."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        New generalized and single epileptic cases patients who accept and sign the approval form\n        of ethical committee non smoker, no trauma, no use of selenium supplement, no use of zinc\n        supplement, no use of vitamin A supplement, no use of vitamin D supplement, no Weight\n        loss, no Diarrhea, no addiction, no alcohol consumption, no use of certain medications,\n\n        Exclusion Criteria:\n\n        presence of above criteria as well as, generalized and single epileptic cases under\n        treatment"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "50 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "all generalized and single epileptic patiants which were identify for fist  time"
            }
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "January 5, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01764516", 
            "org_study_id": "f110@1958", 
            "secondary_id": [
                "f110@19588", 
                "f110@19588", 
                "f110@19588"
            ]
        }, 
        "intervention_browse": {
            "mesh_term": "Selenium"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "zinc", 
            "selenium", 
            "serum", 
            "epilepsy", 
            "antioxidants"
        ], 
        "lastchanged_date": "January 5, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Arak", 
                    "country": "Iran, Islamic Republic of", 
                    "state": "Central province"
                }, 
                "name": "Vali-Asr Hospital"
            }
        }, 
        "location_countries": {
            "country": "Iran, Islamic Republic of"
        }, 
        "number_of_groups": "6", 
        "official_title": "Arak University of Medical Sciences , Ministry of Health and Education,I.R.Iran", 
        "overall_official": {
            "affiliation": "Department of Biochemistry,Arak medical sciences university", 
            "last_name": "Heidar N Farahani, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": [
                "Iran: Ethics Committee", 
                "Iran: Ministry of Health"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "decrement in serum zinc and selenium level", 
            "measure": "Study on Serum Zinc and Selenium Levels in Epileptic Patients", 
            "safety_issue": "Yes", 
            "time_frame": "5 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01764516"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Arak University of Medical Sciences", 
            "investigator_full_name": "Dr. Farahani Heidar", 
            "investigator_title": "faculity of medicine, department of biochemistry", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Comparison between  the selenium  levels by gender in two groups", 
            "safety_issue": "Yes", 
            "time_frame": "5 months"
        }, 
        "source": "Arak University of Medical Sciences", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Arak University of Medical Sciences", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2011", 
        "study_design": "Observational Model: Case Control, Time Perspective: Cross-Sectional", 
        "study_type": "Observational [Patient Registry]", 
        "target_duration": "1 Week", 
        "verification_date": "January 2013"
    }
}